145 related articles for article (PubMed ID: 22101816)
21. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release.
Yasuda J; Hunter E
J Virol; 1998 May; 72(5):4095-103. PubMed ID: 9557699
[TBL] [Abstract][Full Text] [Related]
22. The folding free-energy surface of HIV-1 protease: insights into the thermodynamic basis for resistance to inhibitors.
Noel AF; Bilsel O; Kundu A; Wu Y; Zitzewitz JA; Matthews CR
J Mol Biol; 2009 Apr; 387(4):1002-16. PubMed ID: 19150359
[TBL] [Abstract][Full Text] [Related]
23. Three active forms of aspartic proteinase from Mason-Pfizer monkey virus.
Zábranský A; Andreánsky M; Hrusková-Heidingsfeldová O; Havlícek V; Hunter E; Ruml T; Pichová I
Virology; 1998 Jun; 245(2):250-6. PubMed ID: 9636364
[TBL] [Abstract][Full Text] [Related]
24. Stabilization of the β-hairpin in Mason-Pfizer monkey virus capsid protein- a critical step for infectivity.
Obr M; Hadravová R; DoleŽal M; KříŽová I; Papoušková V; Zídek L; Hrabal R; Ruml T; Rumlová M
Retrovirology; 2014 Oct; 11():94. PubMed ID: 25365920
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of a retroviral protease proves relationship to aspartic protease family.
Miller M; Jaskólski M; Rao JK; Leis J; Wlodawer A
Nature; 1989 Feb; 337(6207):576-9. PubMed ID: 2536902
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer-associated protein--a novel binding partner of Mason-Pfizer monkey virus protease.
Rumlová M; Křížová I; Hadravová R; Doležal M; Strohalmová K; Keprová A; Pichová I; Ruml T
J Gen Virol; 2014 Jun; 95(Pt 6):1383-1389. PubMed ID: 24659101
[TBL] [Abstract][Full Text] [Related]
27. Structural Determinants of Virion Assembly and Release in the C Terminus of the Mason-Pfizer Monkey Virus Capsid Protein.
Buckmaster MV; Zadrozny KK; Ganser-Pornillos BK; Pornillos O; Goff SP
J Virol; 2021 Sep; 95(19):e0061521. PubMed ID: 34287037
[TBL] [Abstract][Full Text] [Related]
28. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.
Wlodawer A; Miller M; Jaskólski M; Sathyanarayana BK; Baldwin E; Weber IT; Selk LM; Clawson L; Schneider J; Kent SB
Science; 1989 Aug; 245(4918):616-21. PubMed ID: 2548279
[TBL] [Abstract][Full Text] [Related]
29. Cloning, bacterial expression, and characterization of the Mason-Pfizer monkey virus proteinase.
Hrusková-Heidingsfeldová O; Andreansky M; Fábry M; Bláha I; Strop P; Hunter E
J Biol Chem; 1995 Jun; 270(25):15053-8. PubMed ID: 7797487
[TBL] [Abstract][Full Text] [Related]
30. The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
Lodermeyer V; Ssebyatika G; Passos V; Ponnurangam A; Malassa A; Ewald E; Stürzel CM; Kirchhoff F; Rotger M; Falk CS; Telenti A; Krey T; Goffinet C
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743357
[TBL] [Abstract][Full Text] [Related]
31. Domain flexibility in retroviral proteases: structural implications for drug resistant mutations.
Rose RB; Craik CS; Stroud RM
Biochemistry; 1998 Feb; 37(8):2607-21. PubMed ID: 9485411
[TBL] [Abstract][Full Text] [Related]
32. Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease.
Sayer JM; Liu F; Ishima R; Weber IT; Louis JM
J Biol Chem; 2008 May; 283(19):13459-70. PubMed ID: 18281688
[TBL] [Abstract][Full Text] [Related]
33. Backbone resonance assignment of protease from Mason-Pfizer monkey virus.
Veverka V; Bauerová H; Zábranský A; Pichová I; Hrabal R
J Biomol NMR; 2001 Jul; 20(3):291-2. PubMed ID: 11519753
[No Abstract] [Full Text] [Related]
34. Interaction Interface of Mason-Pfizer Monkey Virus Matrix and Envelope Proteins.
Prchal J; Sýs J; Junková P; Lipov J; Ruml T
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796061
[TBL] [Abstract][Full Text] [Related]
35. Crystallization and preliminary X-ray studies of dUTPase from Mason-Pfizer monkey retrovirus.
Barabás O; Németh V; Vértessy BG
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Apr; 62(Pt 4):399-401. PubMed ID: 16582495
[TBL] [Abstract][Full Text] [Related]
36. Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.
Ziani W; Bauer A; Lu H; Wang X; Wu X; Bar KJ; Li H; Liu D; Shaw GM; Veazey RS; Xu H
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568508
[TBL] [Abstract][Full Text] [Related]
37. SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.
Dashti A; Waller C; Mavigner M; Schoof N; Bar KJ; Shaw GM; Vanderford TH; Liang S; Lifson JD; Dunham RM; Ferrari G; Tuyishime M; Lam CK; Nordstrom JL; Margolis DM; Silvestri G; Chahroudi A
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817214
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the DIS of stem-loop 1 initiates viral RNA dimerization.
Song R; Kafaie J; Yang L; Laughrea M
J Mol Biol; 2007 Aug; 371(4):1084-98. PubMed ID: 17599354
[TBL] [Abstract][Full Text] [Related]
39. Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.
North TW; Van Rompay KK; Higgins J; Matthews TB; Wadford DA; Pedersen NC; Schinazi RF
J Virol; 2005 Jun; 79(12):7349-54. PubMed ID: 15919889
[TBL] [Abstract][Full Text] [Related]
40. Folded monomer of HIV-1 protease.
Ishima R; Ghirlando R; Tözsér J; Gronenborn AM; Torchia DA; Louis JM
J Biol Chem; 2001 Dec; 276(52):49110-6. PubMed ID: 11598128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
